Champlain Investment Partners, LLC Burning Rock Biotech LTD Transaction History

Champlain Investment Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$6.7 - $10.23 $189,844 - $289,867	-28,335 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$9.43 - $17.14 $17,917 - $32,566	-1,900 Reduced 6.28%	28,335 $270,000
Q3 2021 Nov 12, 2021	BUY	$17.37 - $27.92 $2,431 - $3,908	140 Added 0.47%	30,235 $541,000
Q2 2021 Aug 12, 2021	BUY	$26.14 - $37.45 $786,683 - $1.13 Million	30,095 New	30,095 $887,000

21.2K

Ticker BNR
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 105,188,000
Market Cap $705M
Description
Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based cancer therapy selection and p...

Get notified when there are updates to the investment portfolio of Champlain Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Champlain Investment Partners, LLC with notifications on news.